Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.28 USD
-0.01 (-0.78%)
Updated Apr 23, 2024 09:30 AM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Apyx Medical (APYX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.33 | $9.00 | $2.00 | 243.65% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Apyx Medical comes to $4.33. The forecasts range from a low of $2.00 to a high of $9.00. The average price target represents an increase of 243.65% from the last closing price of $1.26.
Analyst Price Targets (3 )
Broker Rating
Apyx Medical currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/22/2024 | Lake Street Capital Markets | Frank Takkinen | Strong Buy | Strong Buy |
3/21/2024 | JMP Securities | David L Turkaly | Hold | Hold |
3/1/2024 | Piper Sandler | Matthew O'Brien | Hold | Hold |
1/16/2024 | Stephens | George Sellers | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 4 |
Average Target Price | $4.33 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 149 of 252 |
Current Quarter EPS Est: | -0.18 |